From 2016 to 2025, Febbo served as Chief Executive Officer and Director of OptimizeRX Corporation (NASDAQ: OPRX). During his tenure, he transformed OptimizeRX from a single point-of-care product into ...

Law firm Mishcon de Reya, which has Oxbridge offices alongside its London and Asia locations, is committing big money to ...